ArticleNature medicine2026

SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial.

Lauren Averett Byers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.